MAM
NKTR icon

Meeder Asset Management’s Nektar Therapeutics NKTR Stock Holding History

Meeder Asset Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8
Closed – – 1558
2022
Q3 		$0 Sell
8
-1
-11% -$59 ﹤0.01% 2291
2022
Q2 		$1K Sell
9
-20
-69% -$1.26K ﹤0.01% 2039
2022
Q1 		$2K Buy
+29
New +$4.29K ﹤0.01% 2055
2021
Q4 		– Sell
-3
Closed -$1K – 1928
2021
Q3 		$1K Sell
3
-24
-89% -$5.77K ﹤0.01% 2346
2021
Q2 		$7K Buy
27
+23
+575% +$6.37K ﹤0.01% 1830
2021
Q1 		$1K Hold
4
– – ﹤0.01% 2234
2020
Q4 		$1K Sell
4
-1
-20% -$258 ﹤0.01% 1699
2020
Q3 		$1K Sell
5
-8
-62% -$2.52K ﹤0.01% 2014
2020
Q2 		$5K Sell
13
-31
-70% -$9.67K ﹤0.01% 1529
2020
Q1 		$12K Buy
44
+24
+120% +$7.42K ﹤0.01% 1442
2019
Q4 		$7K Buy
20
+3
+18% +$870 ﹤0.01% 1686
2019
Q3 		$5K Sell
17
-1,455
-99% -$534K ﹤0.01% 1767
2019
Q2 		$786K Buy
1,472
+1,419
+2,677% +$712K 0.05% 299
2019
Q1 		$27K Buy
53
+32
+152% +$19K ﹤0.01% 1004
2018
Q4 		$10K Sell
21
-190
-90% -$115K ﹤0.01% 1253
2018
Q3 		$194K Sell
211
-217
-51% -$185K 0.01% 508
2018
Q2 		$313K Buy
428
+294
+219% +$339K 0.03% 436
2018
Q1 		$213K Hold
134
– – 0.02% 446
2017
Q4 		$121K Buy
+134
New +$79.3K 0.01% 540

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Meeder Asset Management's NKTR Position: Q4 2022 in Review

Meeder Asset Management sold out of Nektar Therapeutics (NKTR) in Q4 2022, closing a stake of 8 shares.

Meeder Asset Management first reported a position in NKTR in Q4 2017 and held it in 19 quarters. The position peaked at $786K in Q2 2019. 214 funds tracked by Wall St. Rank hold NKTR as of Q4 2022.

  • Meeder Asset Management reported no remaining Nektar Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 8 Nektar Therapeutics shares in Q4 2022.
  • Meeder Asset Management first reported a position in Nektar Therapeutics in Q4 2017 and held it in 19 quarters.
  • Meeder Asset Management's Nektar Therapeutics position peaked at $786K in Q2 2019.
  • 214 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.